BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26756113)

  • 41. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
    Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
    Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas.
    Perren A; Anlauf M; Henopp T; Rudolph T; Schmitt A; Raffel A; Gimm O; Weihe E; Knoefel WT; Dralle H; Heitz PU; Komminoth P; Klöppel G
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1118-28. PubMed ID: 17179192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
    Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
    Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two nonsense somatic mutations in
    Qi C; Duan J; Shi Q; Wang M; Yan C
    FEBS Open Bio; 2018 Feb; 8(2):295-301. PubMed ID: 29435419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
    Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
    J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
    Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
    Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse.
    Lu J; Hamze Z; Bonnavion R; Herath N; Pouponnot C; Assade F; Fontanière S; Bertolino P; Cordier-Bussat M; Zhang CX
    Oncogene; 2012 Aug; 31(31):3647-54. PubMed ID: 22120711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
    Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status.
    Winston KY; Dawrant J
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):773-6. PubMed ID: 24756045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
    Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
    Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
    J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.
    Jonkers YM; Claessen SM; Veltman JA; Geurts van Kessel A; Dinjens WN; Skogseid B; Ramaekers FC; Speel EJ
    Cytogenet Genome Res; 2006; 115(3-4):289-97. PubMed ID: 17124412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.